Loading
Total declarations
Companies
▲ Purchases (7 ops.)
▼ Sales (3 ops.)
Latest filing published 03 Aug 2026 for KESTRA MEDICAL TECHNOLOGIES, LTD., €172k.
Filing timeline
BuySaleTimothy P. Moran
Insider track record
Disclosed buys
7
Disclosed sells
3
Signal history
Closed purchases
Market purchases
7
Positive at T+90
57%
Median T+90
+18.8%
Based on 7 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -86.1%Entry US$148.89 · Close at T+365 US$20.70
- -54.7%Entry US$336.00 · Close at T+365 US$152.25
- -49.6%Entry US$480.00 · Close at T+365 US$241.71
- -55.4%Entry US$894.00 · Close at T+365 US$399.00
- -61.2%Entry US$1,005.00 · Close at T+365 US$390.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Timothy P. Moran: trading record in brief
Timothy P. Moran, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Motus GI Holdings, Inc. and Kestra Medical Technologies, Ltd. We count 16 filings; the first trade dates from 19 November 2018 and the latest from 3 August 2026.
In open-market terms, that means 7 purchases worth €120k on one side and 3 sales worth €303k on the other. On balance, insiders were net sellers of €183k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 6 share grants. In 2026 alone, the filings show no purchases and 3 sales.
The median purchase comes to €14k. 6 out of 7 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster. Ninety days after publication, 7 purchases show a median change of +18.8%, with the price up in 57% of them. Past outcomes like these are no guarantee of what comes next.
The record was last updated on 3 August 2026 with an open-market sale (€172k) in Kestra Medical Technologies, Ltd. The clock since the last published purchase (22 November 2021) now reads 1,797 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Timothy P. Moran
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
8,759 shares@ US$22.60540.013% mcap28.4% of flowCommon SharesSEC:0001193125-26-331066:1
2,380 shares@ US$23.76110.0036% mcap8.1% of flowCommon SharesSEC:0001193125-26-331066:2
4,117 shares@ US$22.77350.0061% mcap13.5% of flowCommon SharesSEC:0001193125-26-331066:0
39,113 shares0Common SharesSEC:0001193125-26-308047:0
19,557 sharesCommon SharesSEC:0001193125-25-308424:0
175,000 shares0Common Stock, par value $0.0001 per shareSEC:0001493152-22-004067:0
10,000 shares@ US$0.5214100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001213900-21-061012:0
Canonical exit: 17 Feb 2022 (T+90)
141,000 shares0Common Stock, par value $0.0001 per shareSEC:0001213900-21-010581:0
10,000 shares@ US$0.96440.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001213900-20-041229:0
Canonical exit: 4 Mar 2021 (T+90)
103,720 shares0Common Stock, par value $0.0001 per shareSEC:0001213900-20-002929:0
10,000 shares@ US$1.540.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001213900-19-024215:0
Canonical exit: 18 Feb 2020 (T+90)
3,333 shares@ US$3.000.1% of flowCommon Stock, par value $0.0001 per shareSEC:0001213900-19-011867:0
Canonical exit: 29 Sept 2019 (T+90)
5,000 shares@ US$3.380.1% of flowCommon Stock, par value $0.0001 per shareSEC:0001615774-19-008371:0
Canonical exit: 20 Aug 2019 (T+90)
174,648 shares0Common Stock, par value $0.0001 per shareSEC:0001615774-19-002645:0
10,000 shares@ US$2.700.1% of flowCommon Stock, par value $0.0001 per shareSEC:0001615774-18-014977:0
Canonical exit: 24 Mar 2019 (T+90)
15,000 shares@ US$3.480.1% of flowCommon Stock, par value $0.0001 per shareSEC:0001615774-18-013097:0
Canonical exit: 17 Feb 2019 (T+90)
16 of 16 declarations
